|
Real-time Estimate
Cboe BZX
15:20:36 03/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.605 USD | +0.58% |
|
-0.38% | +44.44% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.58% | -0.38% | +12.07% | +32.65% | +44.44% | +62.50% | +36.84% | +61.49% | -58.06% | 209M | |
| -0.56% | -2.16% | +2.62% | +6.67% | +7.08% | +55.96% | +106.15% | +343.39% | +1,365.71% | 1,034B | |
| +0.07% | +3.55% | +8.18% | +23.28% | +32.99% | +54.62% | +71.28% | +57.23% | +129.82% | 663B | |
| -1.06% | +0.57% | +5.92% | +19.57% | +13.62% | +22.54% | +77.70% | +132.59% | +301.83% | 462B | |
| +1.80% | -2.01% | +0.20% | +14.47% | +8.68% | +32.36% | +38.44% | -2.21% | +46.73% | 344B | |
| -0.26% | +5.57% | +5.69% | +15.91% | +20.05% | +27.65% | +47.79% | +57.83% | +68.80% | 307B | |
| +1.08% | +0.46% | +5.83% | -7.87% | -11.75% | -0.33% | +13.84% | +43.03% | +148.22% | 251B | |
| -0.70% | +1.03% | +16.52% | +30.53% | +34.88% | +55.53% | +73.80% | +95.02% | +158.41% | 239B | |
| -0.15% | +3.13% | +0.73% | +12.03% | -6.38% | -16.50% | -53.54% | -3.27% | +98.18% | 207B | |
| -0.56% | -0.02% | +13.48% | +15.38% | +21.26% | +31.72% | +98.02% | +106.82% | +91.10% | 186B | |
| -1.84% | +2.25% | +14.46% | +13.06% | +15.06% | +15.57% | -19.02% | -38.83% | -17.60% | 165B | |
| -0.44% | +1.73% | +18.33% | +30.04% | +22.87% | +40.44% | +59.95% | +181.25% | +481.57% | 141B | |
| -0.79% | +0.54% | +2.81% | +23.01% | +24.79% | +41.71% | +11.00% | +2.59% | +18.17% | 138B | |
| -0.78% | -0.87% | +2.83% | +4.20% | -7.39% | -11.04% | -21.85% | -12.79% | +9.46% | 107B | |
| +0.08% | +1.21% | -1.83% | +1.24% | +2.74% | +27.73% | +36.47% | +1.41% | -8.81% | 101B | |
| +0.67% | -0.99% | +2.86% | -7.34% | -16.56% | +6.73% | +54.88% | +55.89% | +497.22% | 70.85B | |
| +1.44% | +1.70% | +9.25% | +24.43% | +22.19% | +31.32% | +30.33% | +58.60% | +24.22% | 58.62B | |
| +0.82% | +2.48% | +5.43% | +43.17% | +34.23% | +77.21% | -1.90% | +4.64% | -47.28% | 56.01B | |
| -1.43% | -2.50% | -15.74% | -5.85% | -23.50% | -33.83% | +9.73% | -0.63% | +175.93% | 44.63B | |
| -2.28% | -2.33% | -0.39% | +12.36% | -3.71% | -2.64% | +14.32% | - | - | 43.54B | |
| Average | -0.18% | -0.72% | +5.46% | +15.05% | +11.78% | +25.96% | +34.21% | +60.21% | +183.35% | 230.99B | |
| Weighted average by Cap. | -0.19% | -0.61% | +5.75% | +14.22% | +13.45% | +34.74% | +57.12% | +120.18% | +414.51% |
- Stock Market
- Stocks
- PLX Stock
- Sector Protalix BioTherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
